Quintrio
Home

Stock overview

Instinct Bio Technical Company Holdings Inc. Ordinary Shares

BIOT

Instinct Bio Technical Company Holdings Inc is a Cayman Islands-based vertically integrated group engaged in the research and development, manufacturing, branding, and distribution of stem cells, regenerative medicine, wellness, and beauty as its core areas. Its product portfolio includes stem cell-derived serums and skincare formulations for aesthetic and dermatological applications. The company also develops regenerative products for skin healing, hydration, and elasticity.

Last trade $0.1851
Day change -$0.0029 (-1.54%)
Day range $0.182 – $0.197
Volume 126,872
Market cap $5M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for BIOT.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for BIOT.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio announced progress on its Indonesia expansion, securing a 213 m² premises in South Jakarta for its first GENRÊVER CLINIC site targeting opening by end of December 2026, with subscription pricing at $400-$3,000 monthly. The company is developing cosmetic product lines with manufacturing partners INVITRX (US-based) and PT PARVA CANDELA (Indonesia-based), with production targeted for 2026.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.